The Journal of Clinical Investigation (Oct 2023)

STING activation promotes autologous type I interferon–dependent development of type 1 regulatory T cells during malaria

  • Yulin Wang,
  • Fabian De Labastida Rivera,
  • Chelsea L. Edwards,
  • Teija C.M. Frame,
  • Jessica A. Engel,
  • Luzia Bukali,
  • Jinrui Na,
  • Susanna S. Ng,
  • Dillon Corvino,
  • Marcela Montes de Oca,
  • Patrick T. Bunn,
  • Megan S.F. Soon,
  • Dean Andrew,
  • Jessica R. Loughland,
  • Jia Zhang,
  • Fiona H. Amante,
  • Bridget E. Barber,
  • James S. McCarthy,
  • J. Alejandro Lopez,
  • Michelle J. Boyle,
  • Christian R. Engwerda

Journal volume & issue
Vol. 133, no. 19

Abstract

Read online

The development of highly effective malaria vaccines and improvement of drug-treatment protocols to boost antiparasitic immunity are critical for malaria elimination. However, the rapid establishment of parasite-specific immune regulatory networks following exposure to malaria parasites hampers these efforts. Here, we identified stimulator of interferon genes (STING) as a critical mediator of type I interferon production by CD4+ T cells during blood-stage Plasmodium falciparum infection. The activation of STING in CD4+ T cells by cyclic guanosine monophosphate-adenosine monophosphate (cGAMP) stimulated IFNB gene transcription, which promoted development of IL-10– and IFN-γ–coproducing CD4+ T (type I regulatory [Tr1]) cells. The critical role for type I IFN signaling for Tr1 cell development was confirmed in vivo using a preclinical malaria model. CD4+ T cell sensitivity to STING phosphorylation was increased in healthy volunteers following P. falciparum infection, particularly in Tr1 cells. These findings identified STING expressed by CD4+ T cells as an important mediator of type I IFN production and Tr1 cell development and activation during malaria.

Keywords